关注
Xavier Delavenne
Xavier Delavenne
Université Jean Monnet, Saint-Etienne
在 chu-st-etienne.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I Gouin‐Thibault, X Delavenne, A Blanchard, V Siguret, JE Salem, ...
Journal of Thrombosis and Haemostasis 15 (2), 273-283, 2017
1752017
Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies
S Laporte, C Chapelle, P Caillet, MN Beyens, F Bellet, X Delavenne, ...
Pharmacological research 118, 19-32, 2017
1512017
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays
I Gouin-Thibault, C Flaujac, X Delavenne, S Quenet, MH Horellou, ...
Thrombosis and haemostasis 112 (02), 240-248, 2014
1442014
Prevalence of poor biological response to clopidogrel
N Mallouk, C Labruyère, JL Reny, C Chapelle, M Piot, P Fontana, JC Gris, ...
Thrombosis and haemostasis 107 (03), 494-506, 2012
1092012
Towards optimization of hydroxychloroquine dosing in intensive care unit COVID-19 patients
S Perinel, M Launay, É Botelho-Nevers, É Diconne, A Louf-Durier, ...
Clinical infectious diseases 71 (16), 2227-2229, 2020
1052020
UPLC MS/MS assay for routine quantification of dabigatran–a direct thrombin inhibitor–in human plasma
X Delavenne, J Moracchini, S Laporte, P Mismetti, T Basset
Journal of pharmaceutical and biomedical analysis 58, 152-156, 2012
962012
A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin
X Delavenne, E Ollier, T Basset, L Bertoletti, S Accassat, A Garcin, ...
British journal of clinical pharmacology 76 (1), 107-113, 2013
932013
Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study
X Delavenne, P Mismetti, T Basset
Journal of pharmaceutical and biomedical analysis 78, 150-153, 2013
712013
In vitro comparison of the role of P-glycoprotein and breast cancer resistance protein on direct oral anticoagulants disposition
S Hodin, T Basset, E Jacqueroux, O Delezay, A Clotagatide, N Perek, ...
European journal of drug metabolism and pharmacokinetics 43, 183-191, 2018
652018
Exposure–response relationship of tranexamic acid in cardiac surgery: a model-based meta-analysis
PJ Zufferey, J Lanoiselee, B Graouch, B Vieille, X Delavenne, E Ollier
Anesthesiology 134 (2), 165-178, 2021
542021
UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: application to pharmacokinetic study
X Delavenne, L Juthier, B Pons, C Mariat, T Basset
Clinica chimica acta 412 (1-2), 59-65, 2011
492011
Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies
C Puech, S Hodin, V Forest, Z He, P Mismetti, X Delavenne, N Perek
International journal of pharmaceutics 551 (1-2), 281-289, 2018
482018
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants
G Jourdi, M Delrue, A Stepanian, J Valaize, G Foulon-Pinto, J Demagny, ...
Thrombosis Research 184, 86-91, 2019
452019
Pharmacological characterization of the 3D MucilAir™ nasal model
C Mercier, E Jacqueroux, Z He, S Hodin, S Constant, N Perek, D Boudard, ...
European Journal of Pharmaceutics and Biopharmaceutics 139, 186-196, 2019
432019
Direct oral anticoagulants: current indications and unmet needs in the treatment of venous thromboembolism
L Bertoletti, E Ollier, C Duvillard, X Delavenne, MN Beyens, ...
Pharmacological research 118, 33-42, 2017
432017
Individualized PK‐based prophylaxis in severe haemophilia
Y Dargaud, X Delavenne, DP Hart, S Meunier, P Mismetti
Haemophilia 24, 3-17, 2018
372018
Ultra‐performance LC MS/MS method for quantification of clopidogrel active metabolite
X Delavenne, T Basset, P Zufferey, N Malouk, S Laporte, P Mismetti
Journal of separation science 33 (13), 1968-1972, 2010
372010
In vitro and in vivo evaluation of drug–drug interaction between dabigatran and proton pump inhibitors
E Ollier, S Hodin, T Basset, S Accassat, L Bertoletti, P Mismetti, ...
Fundamental & clinical pharmacology 29 (6), 604-614, 2015
362015
Intravenous tranexamic acid bolus plus infusion is not more effective than a single bolus in primary hip arthroplasty: a randomized controlled trial
PJ Zufferey, J Lanoiselée, C Chapelle, DB Borisov, JY Bien, P Lambert, ...
Anesthesiology 127 (3), 413-422, 2017
352017
Effect of activated charcoal on rivaroxaban complex absorption
E Ollier, S Hodin, J Lanoiselée, J Escal, S Accassat, E De Magalhaes, ...
Clinical Pharmacokinetics 56, 793-801, 2017
352017
系统目前无法执行此操作,请稍后再试。
文章 1–20